Bolt Biotherapeutics, Inc. Restructuring Reserve
Bolt Biotherapeutics, Inc. (BOLT) had Restructuring Reserve of $0 as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2025-11-12
- 2025-09-30: Restructuring Reserve $0.00.
- 2025-06-30: Restructuring Reserve $39.00K.
- 2025-03-31: Restructuring Reserve $296.00K.
- 2024-12-31: Restructuring Reserve $739.00K.
| Period end | Restructuring Reserve |
|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 |
| 2025-06-30 | $39.00K 10-Q · filed 2025-11-12 |
| 2025-03-31 | $296.00K 10-Q · filed 2025-08-14 |
| 2024-12-31 | $739.00K 10-Q · filed 2025-11-12 |
| 2024-09-30 | $1.54M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $2.90M 10-K · filed 2025-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |